A critical call for clearer diagnostic criteria, incentivized screening, and increased awareness to improve outcomes and reduce costs
Despite affecting up to 10% of women of reproductive age worldwide and representing one of the most common gynecological conditions, endometriosis remains notorious for its lengthy diagnostic delays. Many patients wait an average of seven to ten years after symptom onset before receiving an accurate diagnosis, with profound consequences for their health, quality of life, and the healthcare system.
Why Diagnostic Delay Persists
Endometriosis occurs when tissue resembling the uterine lining grows outside the uterus, leading to inflammation, scarring, pain, and fertility issues. Symptoms vary widely and can include severe menstrual pain, chronic pelvic pain, gastrointestinal symptoms, and fatigue. Because the root causes remain unclear and the only definitive diagnosis requires surgery, delays are common.
Several factors contribute to this delay:
- Underfunding of Research: Research funding in the US is disproportionately low, about $2 per diagnosed patient in 2022, compared to diseases like Crohn’s, which received 65 times more funding per patient. This disparity reflects the broader underfunding of diseases that primarily affect women.
- Complexity of Diagnosis: Symptoms mimic other conditions, and diagnosis often requires diagnostic laparoscopy, a surgical procedure. Physicians often need to rule out multiple other diagnoses first.
- Social and Clinical Biases: Healthcare providers frequently dismiss severe menstrual pain as “normal,” and implicit biases can lead to disparities in care. Also, lack of awareness in medical training limits early recognition.
- Financial Barriers: Specialized diagnostic procedures and treatment can be expensive, disproportionately limiting access for marginalized groups.
Proposed Policy Solutions
The article advocates several systemic interventions:
- Establish Clearer Diagnostic Criteria
Standardized diagnostic guidelines should be universally adopted to facilitate earlier suspicion and referral. - Implement Routine Screening
Incentivized, routine screening tools during healthcare visits could help identify women at risk earlier. Validated questionnaires for symptom assessment exist that could prompt specialist referral. - Incentivize Screening Implementation
Instead of mandatory screening laws, financial incentives for healthcare providers or payers can encourage rapid adoption of screening protocols. - Increase Awareness and Training
Medical education reforms are critical to raise awareness among general clinicians and improve diagnostic accuracy in initial care settings. - Boost Research Funding
Expanded funding is needed to better understand the disease and develop less invasive diagnostic methods.
Economic and Quality of Life Benefits
Reducing diagnostic delays not only helps patients, preventing prolonged suffering, mental health impacts, and relationship stress, but could also lead to significant economic savings. The annual healthcare burden of endometriosis in the US is estimated between $78 billion and $119 billion. Delays lead to unnecessary emergency visits, misdirected treatments, and lost productivity.
Sources
- Penzer AJ, Schweikart SJ. Using Policy and Law to Help Reduce Endometriosis Diagnostic Delay. AMA Journal of Ethics. 2025 Feb;27(2):E104-109. DOI: 10.1001/amajethics.2025.104. Available at: https://journalofethics.ama-assn.org/article/using-policy-and-law-help-reduce-endometriosis-diagnostic-delay/2025-02
- National Institutes of Health. Endometriosis Research Funding Data. 2022 Report.
- Healthcare Cost and Utilization Project. Economic Burden of Endometriosis in the United States. 2024.
